Apollo Hospitals Enterprise Limited (APOLLOHOSP:NSE) Stock Forecast
Show ratings and price targets of :
Alert
Its only available to paid users.
INR 6,333.33
(+4.27%)
Based on the Apollo Hospitals Enterprise Limited stock forecast from 4 analysts, the average analyst target price for Apollo Hospitals Enterprise Limited is INR 6,333.33 over the next 12 months. Apollo Hospitals Enterprise Limited’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Apollo Hospitals Enterprise Limited is Slightly Bearish, which is based on 7 positive signals and 9 negative signals. At the last closing, Apollo Hospitals Enterprise Limited’s stock price was INR 6,074.15. Apollo Hospitals Enterprise Limited’s stock price has changed by -6.41% over the past week, -1.02% over the past month and +40.00% over the last year.
No recent analyst target price found for Apollo Hospitals Enterprise Limited
No recent average analyst rating found for Apollo Hospitals Enterprise Limited
Company Overview Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India and internationally. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care facilities. It offers services in cardiac sciences, orthopedics, oncology, neurosciences, emergency, robotic surgery, and transplants; and cardiology, neurology, gastroenterology, dermatology, ophthalmology, pediatric, endocrinology, gynecology, urology, nephrology, pulmonology, rheumatology, neurosurgery, radiology, plastic-surgery, neonatology, vascular-surgery, psychiatry, dentistry, ear, nose, and throat care services. The company also provides other services, such as project consultancy, health insurance, medical colleges, medvarsity for e-learning, and research services. In addition, it operates pharmacies, primary care clinics, birthing centers, specialized birthing centers, dialysis centers, cradle and fertility centers, diabetes management centers, single specialty clinics, primary health centers and diagnostic chains, dental clinics, and daycare and home healthcare centers. Further, the company engages in the business of bio-banking of tissues. The company serves through national retail healthcare centers and genomics institutes, as well as Apollo 24/7, a digital health platform; and www.apollopharmacy.in, an online pharmacy. Apollo Hospitals Enterprise Limited was incorporated in 1979 and is based in Chennai, India. Address: Sunny Side Building, Chennai, India, 600006 Read Less
Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India and internationally. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthc...Read More
Frequently Asked Questions About Apollo Hospitals Enterprise Limited (APOLLOHOSP:NSE) Stock
Based on ratings from 4 analysts Apollo Hospitals Enterprise Limited's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 2 buy, sell and 2 hold ratings.
APOLLOHOSP:NSE stock's dividend yield is 0.24%.
Our analysis grades APOLLOHOSP:NSE stock's dividend yield at F. This means that APOLLOHOSP:NSE stock's dividend yield is above 50% of the stocks in the Medical Care Facilities sector in the NSE exchange.
Based on this APOLLOHOSP:NSE may be a average dividend stock for its sector.
Based on targets from 4 analysts, the average taret price for APOLLOHOSP:NSE is INR 6,333.33 over the next 12 months. The maximum analyst target price is INR 7050 while the minimum anlayst target price is INR 5880.
APOLLOHOSP:NSE stock's Price/Earning ratio is 110.22.
Our analysis grades APOLLOHOSP:NSE stock's Price / Earning ratio at F. This means that APOLLOHOSP:NSE stock's Price/Earning ratio is above 86% of the stocks in the Medical Care Facilities sector in the NSE exchange.
Based on this APOLLOHOSP:NSE may be a overvalued for its sector.
The last closing price of APOLLOHOSP:NSE's stock was INR 6,074.15.
The most recent market capitalization for APOLLOHOSP:NSE is INR 873.37B.
Based on targets from 4 analysts, the average taret price for APOLLOHOSP:NSE is projected at INR 6,333.33 over the next 12 months.
This means that APOLLOHOSP:NSE's stock price may go up by +4.27% over the next 12 months.
We can't find any ETFs which contains Apollo Hospitals Enterprise Limited's stock.
As per our most recent records Apollo Hospitals Enterprise Limited has 83,147 Employees.
Apollo Hospitals Enterprise Limited's registered address is Sunny Side Building, Chennai, India, 600006.
You can get more information about it from Apollo Hospitals Enterprise Limited's website at https://www.apollohospitals.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
High dividend returns
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
What not to like
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for APOLLOHOSP:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
